'Toxgnostics': an unmet need in cancer medicine
@article{Church2014ToxgnosticsAU, title={'Toxgnostics': an unmet need in cancer medicine}, author={D. Church and R. Kerr and E. Domingo and Dan Rosmarin and C. Palles and K. Maskell and I. Tomlinson and D. Kerr}, journal={Nature Reviews Cancer}, year={2014}, volume={14}, pages={440-445} }
If we were to summarize the rationale that underpins medical oncology in a Latin aphorism, it might be 'veneno ergo sum'; that is, I poison, therefore I am. The burden of chemotherapy-associated toxicity is well recognized, but we have relatively few tools that increase the precision of anticancer drug prescribing. We propose a shift in emphasis from the focussed study of polymorphisms in drug metabolic pathways in small sets of patients to broader agnostic analyses to systematically correlate… CONTINUE READING
Figures and Topics from this paper
Figures
22 Citations
Cancer predisposition syndromes: lessons for truly precision medicine
- Medicine
- The Journal of pathology
- 2017
- 6
Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies
- Medicine
- Indian Journal of Surgical Oncology
- 2016
- 1
- PDF
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
- Medicine
- Breast Cancer Research and Treatment
- 2015
- 9
The Pharmaceutical Applications of Next Generation Sequencing in Oncology Drug Designing and Development
- Medicine
- 2015
- 4
Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
- Medicine, Biology
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- 2018
- 14
Clinical cancer research: the past, present and the future
- Medicine
- Nature Reviews Clinical Oncology
- 2014
- 23
The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
- Medicine
- International journal of radiation oncology, biology, physics
- 2016
- 76
Prognostic markers for colorectal cancer: estimating ploidy and stroma
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2018
- 24
References
SHOWING 1-10 OF 98 REFERENCES
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients
- Medicine
- Pharmacogenetics and genomics
- 2011
- 14
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2014
- 160
- PDF
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?
- Medicine
- Clinical colorectal cancer
- 2010
- 76
Review: side effects of approved molecular targeted therapies in solid cancers.
- Medicine
- The oncologist
- 2007
- 261
- PDF
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
- Biology, Medicine
- British Journal of Cancer
- 2013
- 106
5-Fluorouracil: mechanisms of action and clinical strategies
- Biology, Medicine
- Nature Reviews Cancer
- 2003
- 3,213
- PDF
Genetic prognostic and predictive markers in colorectal cancer
- Medicine
- Nature Reviews Cancer
- 2009
- 378
- PDF
Severe 5‐fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
- Medicine
- Cancer
- 1991
- 213
Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity
- Medicine
- Clinical pharmacology and therapeutics
- 2013
- 16
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1996
- 141